Abstract P5-15-13: Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Final PFS results of a phase II trial (AGMT MBC-6)

Autor: G Rinnerthaler, SP Gampenrieder, D Voskova, A Petzer, M Hubalek, E Petru, B Hartmann, J Andel, M Balic, T Melchardt, H Ulmer, B Mlineritsch, R Greil

Publikováno v: Cancer Research. 77:P5-15

Background: Capecitabine is a well-established treatment option in HER2-negative advanced breast cancer (ABC) patients. Bendamustine is a generally well tolerated cytotoxic drug. Since bendamustine has already shown anticancer activity in ABC we eval

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b179fd0087ebcf639697d7c9b9a1e1a9
https://doi.org/10.1158/1538-7445.sabcs16-p5-15-13

Clinical applications of next-generation sequencing-based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression.

Autor: Klocker EV; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Austria., Hasenleithner S; Institute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Austria., Bartsch R; Division of Oncology, Department of Medicine I, Medical University of Vienna, Austria., Gampenrieder SP; Third Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University Salzburg, Austria., Egle D; Department of Gynecology, Breast Cancer Center Tirol, Medical University of Innsbruck, Austria., Singer CF; Department of Gynecology, Breast Cancer Center Vienna, Medical University of Vienna, Austria., Rinnerthaler G; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Austria., Hubalek M; Department of Gynecology, Breast Health Center Schwaz, Austria., Schmitz K; Institute of Pathology, University Medical Center Göttingen, Germany.; Tyrolpath Obrist Brunhuber GmbH and Krankenhaus St. Vinzenz, Zams, Austria., Bago-Horvath Z; Department of Pathology, Medical University Vienna, Austria., Petzer A; Department of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Barmherzige Schwestern, Elisabethinen, Ordensklinikum Linz GmbH, Austria., Heibl S; Department of Internal Medicine IV, Klinikum Wels-Grieskirchen GmbH, Austria., Heitzer E; Institute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Christian Doppler Laboratory for Liquid Biopsies for early Detection of Cancer, Medical University of Graz, Austria., Balic M; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Austria.; Division of Hematology and Medical Oncology, University of Pittsburgh School of Medicine, PA, USA., Gnant M; Comprehensive Cancer Center, Medical University of Vienna, Austria.

Publikováno v: Molecular oncology [Mol Oncol] 2024 Jun 12. Date of Electronic Publication: 2024 Jun 12.

Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer-results from an international, multicenter analysis coordinated by the AGMT Study Group.

Autor: Gampenrieder SP; Salzburg Cancer Research Institute- Center for Clinical Cancer and Immunology Trials, Salzburg, Austria; Cancer Cluster Salzburg, Salzburg, Austria; IIIrd Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg, Austria., Dezentjé V; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lambertini M; Medical Oncology Department, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino Genova, Genova, Italy; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, Università di Genova, Genova, Italy., de Nonneville A; Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Univ, CNRS, INSERM, Marseille, France., Marhold M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Le Du F; Département d'oncologie médicale, Centre Eugène-Marquis, Rennes, France., Cortés Salgado A; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Alpuim Costa D; Haematology and Oncology Department, CUF Oncologia, Lisbon, Portugal; NOVA Medical School, (NMS), Faculdade de Ciências Médicas (FCM), Lisbon, Portugal; Centro de Medicina Subaquática e Hiperbárica (CMSH), Marinha Portuguesa, Lisbon, Portugal., Vaz Batista M; Oncology Department, Hospital Professor Doutor Fernando Fonseca, Amadora, Portugal., Chic Ruché N; Department of Medical Oncology, Hospital Clínic Barcelona, Barcelona, Spain., Tinchon C; Department for Haemato-Oncology, LKH Hochsteiermark-Leoben, Leoben, Austria., Petzer A; Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz Barmherzige Schwestern-Elisabethinen, Linz, Austria., Blondeaux E; U.O. Epidemiology Unit, IRCCS Ospedale Policlinico San Martino Genova, Genova, Italy., Del Mastro L; Medical Oncology Department, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino Genova, Genova, Italy; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, Università di Genova, Genova, Italy., Targato G; Dipartimento di Oncologia, Ospedale Santa Maria della Misericordia di Udine, Udine, Italy., Bertucci F; Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Univ, CNRS, INSERM, Marseille, France., Gonçalves A; Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Univ, CNRS, INSERM, Marseille, France., Viret F; Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Univ, CNRS, INSERM, Marseille, France., Bartsch R; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Mannsbart C; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Deleuze A; Département d'oncologie médicale, Centre Eugène-Marquis, Rennes, France., Robert L; Département d'oncologie médicale, Centre Eugène-Marquis, Rennes, France., Saavedra Serrano C; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Gion Cortés M; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Sampaio-Alves M; Faculdade de Medicina, Universidade do Porto (FMUP), Oporto, Portugal., Vitorino M; Oncology Department, Hospital Professor Doutor Fernando Fonseca, Amadora, Portugal., Pecen L; Institute of Computer Science, Czech Academy of Sciences, Praha, Czech Republic; Faculty of Medicine in Pilsen - Charles University, Pilsen, Czech Republic., Singer C; Department of Obstetrics and Gynecology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Harbeck N; Breast Center, Department of Gynecology and Obstetrics, Comprehensive Cancer Center of the Ludwig-Maximilians-University, Munich, Germany., Rinnerthaler G; Salzburg Cancer Research Institute- Center for Clinical Cancer and Immunology Trials, Salzburg, Austria; Cancer Cluster Salzburg, Salzburg, Austria; IIIrd Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg, Austria., Greil R; Salzburg Cancer Research Institute- Center for Clinical Cancer and Immunology Trials, Salzburg, Austria; Cancer Cluster Salzburg, Salzburg, Austria; IIIrd Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg, Austria. Electronic address: r.greil@salk.at.

Publikováno v: ESMO open [ESMO Open] 2023 Feb; Vol. 8 (1), pp. 100747. Date of Electronic Publication: 2022 Dec 21.

Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer.

Autor: Gnant M; Medical University of Vienna, Comprehensive Cancer Center, Vienna.; ABCSG (Austrian Breast & Colorectal Cancer Study Group), Vienna., Frantal S; ABCSG (Austrian Breast & Colorectal Cancer Study Group), Vienna., Pfeiler G; Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna., Steger GG; Department of Internal Medicine I, Medical University of Vienna, Vienna., Egle D; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria., Greil R; Department of Internal Medicine III, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute, Center for Clinical Cancer and Immunology Trials; Cancer Cluster Salzburg, Salzburg, Austria., Fitzal F; Department of General Surgery and Breast Health Center of the Comprehensive Cancer Center, Medical University of Vienna, Vienna., Wette V; Breast Center Carinthia, St. Veit, Austria., Balic M; Division of Oncology, Department of Internal Medicine, and Comprehensive Cancer Center, Medical University of Graz, Graz, Austria., Haslbauer F; Department of Internal Medicine, Salzkammergut Klinikum Hospital Vöcklabruck, Vöcklabruck, Austria., Melbinger-Zeinitzer E; Department of Surgery, Hospital Wolfsberg, Wolfsberg, Austria., Bjelic-Radisic V; Department of Gynecology and Obstetrics, Medical University of Graz, Graz, Austria.; Breast Unit, Helios University Hospital Wuppertal, Wuppertal Germany, University Witten/Herdecke, Germany., Artner-Matuschek S; Department of Gynecology, Hanusch Hospital Vienna, Vienna., Kainberger F; Division of Neuro- and Musculoskeletal Radiology, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna., Ritter M; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria., Rinnerthaler G; Department of Internal Medicine III, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute, Center for Clinical Cancer and Immunology Trials; Cancer Cluster Salzburg, Salzburg, Austria., Sevelda P; Department of Gynecology, Karl Landsteiner Institute for Gynecologic Oncology and Senology, Hospital Hietzing, Vienna., Bergh J; Department of Oncology-Pathology, Cancer Research Karolinska Institutet, Stockholm., Kacerovsky-Strobl S; Department of General Surgery and Breast Health Center of the Comprehensive Cancer Center, Medical University of Vienna, Vienna.; Breast Health Center, St. Francis Hospital Vienna, Vienna., Suppan C; Division of Oncology, Department of Internal Medicine, and Comprehensive Cancer Center, Medical University of Graz, Graz, Austria., Brunner C; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria., Deutschmann C; Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna., Gampenrieder SP; Department of Internal Medicine III, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute, Center for Clinical Cancer and Immunology Trials; Cancer Cluster Salzburg, Salzburg, Austria., Fohler H; ABCSG (Austrian Breast & Colorectal Cancer Study Group), Vienna., Jakesz R; Department of General Surgery and Breast Health Center of the Comprehensive Cancer Center, Medical University of Vienna, Vienna., Fesl C; ABCSG (Austrian Breast & Colorectal Cancer Study Group), Vienna., Singer C; Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna.

Publikováno v: NEJM evidence [NEJM Evid] 2022 Dec; Vol. 1 (12), pp. EVIDoa2200162. Date of Electronic Publication: 2022 Nov 18.

Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force.

Autor: Razis E; 3rd Oncology Department, Hygeia Hospital, Athens, Greece. Electronic address: erazis@hygeia.gr., Escudero MJ; GEICAM Spanish Breast Cancer Group, Madrid, Spain. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Palmieri C; University of Liverpool, England; The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Mueller V; University Medical Center, Hamburg, Germany. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Bartsch R; Medical University of Vienna, Austria. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Rossi G; Breast International Group (BIG), Brussels, Belgium. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Gampenrieder SP; Department of Internal Medicine III, Salzburg Cancer Research Institute-CCCIT, Paracelsus Medical University of Salzburg, Austria; Cancer Cluster Salzburg, Austria. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Kolberg HC; Marienhospital Bottrop, Germany. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Zdenkowski N; The Breast Centre, Gateshead, NSW, Australia. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Pavic M; Faculté de médecine et des sciences de la santé (FMSS), Université de Sherbrooke, Quebec, Canada. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Connolly RM; Cancer Research @UCC, University College Cork and Cancer Trials, Ireland. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Rosset L; Centre du Sein Fribourg, Switzerland. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Arcuri J; Centro Medico San Roque, Tucuman, Argentina. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Tesch H; Onkologische Gemeinschaftspraxis am Bethanien Krankenhaus, Frankfurt, Germany. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Vallejos C; Oncosalud, Lima, Peru. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Retamales J; GOCCHI, Santiago, Chile. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Musolino A; Italian Oncology Group for Clinical Research (GOIRC), Parma, Italy; Department of Medicine and Surgery, Medical Oncology and Breast Unit, University of Parma, Italy; University Hospital of Parma, Italy. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Del Mastro L; IRCCS Ospedale Policlinico San Martino, Genoa, Italy; Medicine and Medical Specialities, School of Medicine, University of Genoa, Italy. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Christodoulou C; Second Department of Medical Oncology, Metropolitan Hospital, Athens, Greece. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Aebi S; Division of Medical Oncology, Cantonal Hospital, Cancer Center, Lucerne, Switzerland. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Paluch-Shimon S; Sharett Institute of Oncology, Hadassah University Hospital, Jerusalem; Faculty of Medicine Hebrew University, Jerusalem, Israel. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Gupta S; Tata Memorial Centre, Parel, Mumbai, India; Homi Bhabha National Institute, Mumbai, India. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Ohno S; The Cancer Institute Hospital of JFCR, Tokyo, Japan. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Macpherson I; Beatson Institute for Cancer Research, Glasgow, UK. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Ekholm M; Ryhov Hospital, Jönköping, Sweden; Institute of Biomedicine, Sahlgrenska Center for Cancer Research, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Zaman K; Lausanne University Hospital CHUV, Switzerland. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Vidal M; Hospital Clinic de Barcelona, Barcelona, Spain. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Chakiba C; Departement d'oncologie médicale, Institut Bergonié, Bordeaux, France. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Fumagalli D; Breast International Group (BIG), Brussels, Belgium. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Thulin A; Sahlgrenska University Hospital, Gothenburg, Sweden. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Witzel I; University Medical Center, Hamburg, Germany. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Kotecki N; Institut Jules Bordet, Brussels, Belgium. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Gil-Gil M; Institut Català d'Oncologia - Hospital de Bellvitge, Barcelona, Spain. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/., Linderholm B; Sahlgrenska University Hospital, Gothenburg, Sweden. Electronic address: https://facebook.com/https://www.facebook.com/BIGagainstbreastcancer/.

Publikováno v: ESMO open [ESMO Open] 2022 Jun; Vol. 7 (3), pp. 100483. Date of Electronic Publication: 2022 May 13.